A case of resistance of Rhipicephalus microplus (Acari: Ixodidae) to fipronil detected in field trials in the east of Santiago del Estero, Argentina
DOI:
https://doi.org/10.14409/favecv.v17i1.7158Keywords:
ticks, Boophilus, fipronilAbstract
The resistance of a population of Rhipicephalus microplus (Acari: Ixodidae) to fipronil 1% (ECTOLINE®) in the east of Santiago del Estero, Argentina, is described in this work. The trials were performed as replicates in two establishments: “Establishment A” and “Establishment B”. The differences in the level of tick infestation between treated and control groups in the Establishment A were not significant. The efficacy percentage ranged from 27.3% to 69.3%. Contrarily, the differences between treated and control groups in the Establishment B were significant, with efficacy percentage increasing from 87.6% (day 2 post-treatment) to 95.4% (day 7 post-treatment). The eclosion rates of the eggs produced by the engorged females collected in both treated and control groups in Establishment A were similar. The application of fipronil 1% in the Establishment B had an efficacy almost absolute, because even though the therapeutic efficacy did not reach 100%, the reproductive viability of the engorged females collected on the treated cattle was null. The results of this work constitute the first published record of a population of R. microplus resistant to fipronil 1% under field conditions in Argentina.
References
Downloads
Published
Issue
Section
License
FAVE Sección Ciencias Veterinarias ratifies the open access model, in which contents (in full) are available free to anyone in the internet. The costs of production and publication are not transfered to the authors. This policy intends to break social and economical barriers that generate inequities in the access to information, and for the publication of research results.
All articles can be accessed at http://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/FAVEveterinaria/issue/current/, under license Creative CommonsAtribución-NoComercial-Compartir Igual 4.0 Internacional.






